Vivek Ramaswamy, a biotech and pharmaceutical entrepreneur, entered the public eye by announcing his run for the United States presidency in February 2023. Despite his considerable wealth, reported to be around $950 million, Ramaswamy and his family lead a modest lifestyle, prioritizing community relationships over extravagant displays of affluence.<\/p>\n
Ramaswamy\u2019s fortune began taking shape during his tenure at a hedge fund, where by the age of 28, he had amassed $7 million. At 29, he founded Roivant Sciences and its subsidiary, Axovant Sciences, focusing on acquiring pharmaceutical drugs that major companies had disregarded. His strategy involved reviving drugs with potential societal value that had been sidelined unjustly. Notably, his acquisition of the Alzheimer\u2019s drug Intepirdine from GlaxoSmithKline for $5 million led to Axovant Sciences\u2019 public offering, elevating the company\u2019s value to an astonishing $3 billion. However, Intepirdine\u2019s clinical trial failures led to a significant decline in the company\u2019s shares, prompting Ramaswamy to step down from his role as CEO in 2021, having secured substantial financial gains from his tenure.<\/p>\n
Ramaswamy further made headlines by criticizing what he termed \u201cwoke\u201d corporate practices in his book, \u201cWoke, Inc.\u201d He expanded his stance by establishing Strive Asset Management in 2022, aiming to counteract politicized corporate behavior and advocating for the empowerment of everyday citizens in the American economy. Strive successfully amassed over $1 billion in assets by September 2023. However, following Ramaswamy\u2019s presidential aspirations, he stepped down as chairman of Strive, leaving the firm\u2019s future trajectory uncertain.<\/p>\n
Ramaswamy\u2019s journey from hedge fund success to biotech entrepreneurship, his outspoken critiques of corporate \u201cwokeness,\u201d and his foray into investment management exemplify a dynamic trajectory marked by significant financial successes and endeavors aimed at social and economic change. As he shifts his focus toward political aspirations, his prior ventures and their ongoing impact on various industries remain an intriguing aspect of his profile.<\/p>\n","protected":false},"excerpt":{"rendered":"
Vivek Ramaswamy, a biotech and pharmaceutical entrepreneur, entered the public eye by announcing his run for the United States presidency\u2026<\/p>\n","protected":false},"author":294,"featured_media":18158,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[156],"class_list":["post-18157","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-celebrity-news","tag-vivek-ramaswamy"],"reading_time":"2 min read","_links":{"self":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/18157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/users\/294"}],"replies":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/comments?post=18157"}],"version-history":[{"count":0,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/18157\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media\/18158"}],"wp:attachment":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media?parent=18157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/categories?post=18157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/tags?post=18157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}